CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
Clinical trials for CHRONIC RHINOSINUSITIS WITH NASAL POLYPS explained in plain language.
Never miss a new study
Get alerted when new CHRONIC RHINOSINUSITIS WITH NASAL POLYPS trials appear
Sign up with your email to follow new studies for CHRONIC RHINOSINUSITIS WITH NASAL POLYPS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug could shrink nasal polyps and ease breathing
Disease control Not yet recruitingThis study tests a new drug called itepekimab in Japanese adults with chronic sinusitis and nasal polyps that are not well controlled by standard treatments. The goal is to see if it can shrink polyps and improve nasal congestion over 52 weeks. About 20 participants will receive …
Matched conditions: CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New drug could shrink nasal polyps and ease breathing
Disease control Not yet recruitingThis study tests an experimental drug called CM326 in 212 adults with chronic sinusitis and nasal polyps. The goal is to see if it can shrink polyps and reduce stuffy nose compared to a placebo. Participants will receive the drug or placebo for 24 weeks, then everyone can get the…
Matched conditions: CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
Phase: PHASE3 • Sponsor: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 05, 2026 11:56 UTC
-
New hope for stuffy noses: drug targets nasal polyps in chinese patients
Symptom relief Not yet recruitingThis study tests a drug called tezepelumab in 230 Chinese adults with chronic sinusitis and nasal polyps. The goal is to see if the drug can shrink polyps and reduce congestion over 24 weeks. Participants receive the drug as an injection, and doctors measure changes using nasal e…
Matched conditions: CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Symptom relief
Last updated May 13, 2026 16:00 UTC